Obejective: Despite recent advances in assisted reproduction techniques, implantation and birth rates remain low. Although embryo quality is considered the main determinant of implantation success, maturity and endometrial receptivity are also important factors to consider. However, what precisely constitutes a receptive endometrium remains uncertain. The objective of this study is to investigate if clomiphene citrate alters the endometrial maturation in infertile patients. Methods: In a prospective self-matched cohort study, the ovulation of women was evaluated in spontaneous and stimulated cycles (with clomiphene citrate). Subjects were submitted to transvaginal ultrasounds to follow the cycle and to determine the day of ovulation. In both cycles, four blood samples (BS1 -at early proliferative phase, BS2 -at mid proliferative phase, BS3 -after ovulation and BS4 -at mid luteal phase) were taken to determine the serum concentrations of FSH, LH, estradiol and progesterone. An endometrial biopsy was performed five days after ovulation in both cycles and sent to Hospital de Clínicas de Porto Alegre pathology lab for analysis and classification according to Noyes criteria. Results: Twenty-two participants completed the study protocol. There were significant differences in FSH BS3 (p =0.001), in LH BS3 and BS4 (p<0.001 and p=0.049, respectively), in estradiol BS2, BS3 and BS4 (p<0.001, p = 0.024 and p<0.001, respectively) and in progesterone BS3 and BS4 (p=0.028 and p<0.001, respectively). Considering Noyes criteria, there was a one-day delay when comparing the stimulated cycle with the spontaneous cycle (p =0.004), and a two-day delay when comparing the stimulated cycle with the biopsy day. Discussion: This study indicates that the ovarian stimulation with clomiphene citrate delays the endometrial maturity, and could possibly impair the implantation process. The antiestrogenic effects of clomiphene citrate in the endometrium may be responsible for this difference and, to avoid this effect, it is suggested to consider the freezeall strategy when using clomiphene citrate for controlled ovarian stimulation, in order to minimize the endometrial asynchrony.
Introduction: During controlled ovarian stimulation, a precision between the LH peak and the oocyte recovery is essential for subsequent manipulation of the gametes. The human chorionic gonadotropin (hCG) is the gold standard to achieve this goal. Objective: This study aims to evaluate the effect of the administration of hCG gonadotropin for final oocyte maturation with different intervals between its use and oocyte retrieval (36 and 38h), analyzing its impact on the oocyte recovery rate and its degree of maturation. Method: A total of 78 patients were submitted to treatment with controlled ovarian stimulation and oocyte recovered between March 2017 and April 2018, in the Pérola Byington Hospital. The patients were randomly divided to be submitted to oocyte recovery at distinct intervals after hCG trigger: after 36 or 38 hours. A comparison was performed about number of follicles predicted on the day of the trigger, number of oocytes collected and number of mature oocytes collected. Results: There was not statistically significant differences in a number of oocytes captured and maturation rate as a function of the different intervals -36h or 38h -between the application of the hCG dose and oocyte retrieval. We also did not identify any case of ovulation that occurred before oocyte retrieval after 36h or 38h of hCG application. Conclusion: The interval between the application of hCG and of oocyte retrieval may vary between 36 and 38 hours without impairing follicle maturation and without risk of ovulation. Objective: Recombinant-human follicle-stimulating hormone (r-hFSH) is used for ovarian stimulation as part of treatment with assisted reproductive technologies (ART), with dosing (both starting dose and during treatment) individualized to optimize safety and efficacy. Reporting rates of OHSS and thromboembolism demonstrate that the risk after ovarian stimulation treatment with GONAL-f is low. Methods: Reports of OHSS and thromboembolism were obtained from the Merck KGaA Global Safety Database from 29-Nov-2000 to 19-Oct-2018. Number of cycles were estimated from sales data based on an average 1875 IU administered per treatment-cycle.
Results: The systematic review identified 45 studies, including 5186 patients exposed to GONAL-f and 5240 treatment-cycles. Overall 272 reported cases of OHSS (reporting rate: 5190 per 100,000 treatment cycles; 5.19%) and 10 cases of severe OHSS (reporting rate: 191 per 100,000 treatment cycles; 0.19%) were identified; no fatal cases. No reports of thromboembolism were identified. In the Global Safety Database, there were 1110 reported cases of OHSS (using MedDRA preferred term=OHSS) and 80 reported cases of thromboembolic events (MedDRA SMQ = Embolic and thromboembolic events). Overall, there have been an estimated 16,525,975 treatment cycles since 29Nov-2000. This resulted in reporting rates for OHSS and thromboembolism of 6.7 per 100,000 treatment cycles (0.007%) and 0.48 per 100,000 treatment cycles (0.0005%), respectively. Three fatal cases were recorded; two fatal cases of OHSS and one fatal case of thromboembolism. Conclusion: GONAL-f has been used for more than 18 years, with low rates of OHSS and thromboembolism. This provides reassurance about using GONAL-f for ovarian stimulation. Reprodutiva, São Paulo -Brasil Objective: To identify male prognostic factors in obstructive azoospermia patients prior to PESA. We analyzed if male age, vasectomy time and sexual hormone levels could affect the quality of sperm from PESA and assisted reproduction outcomes. Methods: Retrospective cohort study of institutional database, between November/2017 to January/2019. Fifty-three patients diagnosed with obstructive azoospermia were included. Patients were submitted to PESA and ICSI were performed if motile sperm were obtained. Sexual hormone data was available from 46 patients. Embryo parameters were also analyzed. Results: Median testosterone and FSH levels were higher in patients which PESA yielded motile sperm (478 vs. 340 ng/dL, p=0.0353 and 5 vs. 3.5 IU/L, p=0.0337, respectively). Male age, BMI, time from vasectomy, estradiol, FSH, LH, and testosterone/estradiol ratio were not different between groups. Patients with testosterone above 350 ng/dL had a higher chance of providing motile sperm (88.9% vs. 50%, p=0.0149), with a relative risk (RR) of 4.1 (95% CI 1.51-11.21) and more likely to result in total sperm count higher than 0.001 millions/mL (p=0.0152, RR 3.87, 95% CI 1. 32-11.36 ). Fertilization, blastocyst and top-quality blastocyst rates were not different between groups. Conclusions: Testosterone levels above 350 ng/dL yields higher sperm concentration and motility in obstructive azoospermia patients after PESA. Men with lower testosterone may be better counselled on hormone managements or more complex procedures, in order to avoid unnecessary interventions. Medicine, Salt Lake City, USA 3 Drug Research and Development Center, Department of Surgery, Federal University of Ceara, Fortaleza, Brazil 4 ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil Objective: To evaluate the global DNA methylation profile in spermatozoa of patients with varicocele, relating to seminal quality and sperm chromatin integrity. Methods: A prospective observational case-control study, that included 26 men with varicocele and 26 fertile men who did not have the disease. Seminal quality was evaluated by spermogram and DNA fragmentation using the chromatin dispersion technique. The incidence of abnormal protamine expression was assessed by quantitative Western blot analysis. The sperm DNA methylation pattern was investigated using the Infinium MethylationEPIC BeadChip Kit 450K platform (Illumina, USA) . Results: Men with varicocele displayed decreased sperm concentrations (p=0.0004) and vitality (p=0.0224), and altered sperm morphologies (p=0.0233), as compared with controls. The sperm DNA fragmentation and protamine ratio were similar between the varicocele and control groups. Whole DNA methylation analysis showed that men with varicocele exhibit hypomethylation of sperm DNA in comparison to the control group without the disease (p=0.0373). The total of 59 CpG sites were identified, out of five were hypermethylated and 54 were hypomethylated in the varicocele group. In regional analyzes, 1695 DNA regions were differentially methylated in men with varicocele, and they were related to gametogenesis, meiotic and meiosis cell cycle, and seminal quality. Conclusion: Besides to decreasing seminal quality, men with varicocele have a differential methylation profile when compared to men without the disease, either in a global, locus-or region-specific analysis. Objective: Apply the Artificial Neural Networks technique in conjunction with the Genetic Algorithm for the determination of success pregnancy from the physiological data of patients submitted to assisted fertilization. Methods: A database of 807 patients was used, which contained the physiological parameters of the patient adopted as input for the Artificial Neural Network, being: age, number of attempts at fertilization, number of oocytes, number and size of ovarian follicles and mass index body. The output parameter adopted was positive or negative live birth. For optimization of the Artificial Neural Network, a Genetic Algorithm technique was used. Results: The results were 77% of the correct for the cases of positive live birth and 76% for the negative live birth. The AUC values for the training data were 0.8743 for live births and 0.8729 for non-birth cases. Those that were for the test data were 0.4753 for success cases and 0.5021 for cases of gestational failure.
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P-11. Use of artificial intelligence to verify gestational success
Conclusion:
The results show that the technique still needs adjustments, since for the training data we obtained great results considering the AUC values, however we did not obtain the same good results for the test data, indicating, thus, the necessity of change or insertion of some parameters from the patients, as input variable for the Artificial Neural Network. Objective: This research used the technique of artificial intelligence -AI together with the technique of digital image processing to classify human embryos according to Gardner. Methods: The database of 225 blastocyst images was obtained from the time-lapse imaging software (EmbryoView-erTMSoftware-Vitrolife-Sweden), and divided into 70%, 15% and 15% for training, testing and validation respectively. In order to determine the input variables of AI, digital image processing was used to standardize the images on their characteristics, resolution and illumination, using a computational algorithm on the MatLab ® platform. At the end we obtained 33 variables that mathematically define the human embryo. Results: For the classification of the expanded blastocyst there was an overall accuracy of 72.7% for the test data and 83.4% for the training data, for the classification of the internal cell mass there was a success of 97% and 86% respectively and for the trofectoderm classification we obtained 78.8% and 84.7% of correct answers. The mean AUCs for the expanded blastocyst were 0.8129 and 0.9165 for the test and training data respectively, for the internal cell mass we obtained 0.9926 and 0.9719 and for the trofectoderm data we obtained mean values of 0.8071 and 0.9409. Conclusion: Based on the results obtained, we observed that the AI technique applied to the classification of human embryos obtained excellent indexes of correctness, which makes it promising as a noninvasive and objective technique, that is, without subjectivity to be used daily in the clinics of assisted reproduction. Support: FAPESP (Process 2017 / 19323-5 Objective: Oocyte freezing is the gold standard technique for fertility preservation. It is believed that the number of vitrified mature oocytes in the oncological population is lower than in patients submitted to elective freezing. The objective of this study was to verify this hypothesis and compare it with clinical and laboratory data. Method: A cross-sectional study, carried out at a reproductive medicine center between 2009 and 2018. The sample consisted of 341 patients divided into two groups: neoplasia (n=39) and elective (n=302). Data were presented as mean±standard deviation or median (IIQ) and percentage, according to the distribution of the variables. Data were analyzed using Student's t-test, Mann-Whitney test or Chi-square test, considering p<0.05. Results: The mean age in the neoplasia group was 36.5±2.4 and in the elective group 31.0±5.5 years (p<0.001). The basal FSH of the neoplasia group was significantly lower when compared to the elective group: 3.8mUI / mL (3.3; 5.5) and 6.8 (5.4; 9.6) mIU / mL groups (p<0.001 ). However, the median of mature oocytes in the neoplasia 7 (3; 12) group was not inferior to the elective group 6 (3; 11) (p=0.75), as the rate of mature oocytes / total oocytes did not show significance statistic: group neoplasia 0.68±0.26 vs. elective group 0.72±0.24 (p=0.48).
Support
Conclusion:
The presence of neoplasias does not seem to influence the number of viable mature oocytes for vitrification when compared to the elective group. This result strengthens the continuity of indication for fertility preservation in this population. It should be noted, however, that studies with larger cases are needed to strengthen this evidence. P-15. Dual trigger is more effective than r-hCG trigger in patients with advanced maternal age and low rates of oocyte retrieval, mature oocyte and blastocyst development in previous r-hCG triggered ICSI cycles L.G.L. Maldonado 1 , A.S. Setti 1,2 , D.P.A.F. Braga 1,2 , A. Iaconelli Jr. 1,2 , E. Borges Jr. 1,2 1 Fertility Medical Group -São Paulo -Brazil 2 Instituto Sapientiae -Centro de Estudos e Pesquisa em Reprodução Assistida -São Paulo -Brazil Objective: To compare ovarian response to controlled ovarian stimulation (COS) and intracytoplasmic sperm injection (ICSI) outcomes between patients in which the trigger of final follicular maturation was achieved with dual trigger or recombinant human chorionic gonadotropin (r-hCG) only. Methods: A case-control within-subject analysis was performed to compare COS and ICSI outcomes in patients which had the first ICSI cycle triggered with r-hCG (r-hCG Group, n=18) and the following ICSI cycle with dual trigger (Dual Trigger Group, n=18). The outcomes that were significantly different were used as cut-offs to select patients that had two ICSI cycles triggered with r-hCG (r-hCG 1 st Cycle Group, n=18, and r-hCG 2 nd Cycle Group, n=18), in order to verify if patients presenting with similar characteristics would also benefit from a following cycle triggered with r-hCG. Results: When repeated cycles (r-hCG only vs. dual trigger) were investigated, it was observed higher oocyte yield, and mature oocyte rate, lower immature oocyte rate, higher fertilization rate, and higher blastocyst development rate in Dual Trigger Group. Higher rates of cycles with embryo transferred and implantation were observed in Dual Trigger Group. When repeated cycles (r-hCG vs. r-hCG) were investigated, lower immature oocyte rate and higher implantation rate were observed in r-hCG Trigger 2 nd Cycle Group. Conclusion: Dual trigger regimen is a more effective approach than r-hCG trigger in patients with maternal age > 37 years-old, and previous low rates of oocyte retrieval, mature oocyte and blastocyst development, yielding improved response to COS, and laboratorial and clinical outcomes. Objective: This study aims to evaluate cycles of patients who performed day four embryo transfer and compare them to blastocyst or cleavage stage embryo transfers. Methods: The study selected patients from January to July 2018 who underwent fresh embryo transfer at day four (D4), three (D3) or five (D5) after oocyte collection. Group D4 was compared to groups D3 and D5. Student's t-test was used to compare age, body mass index, anti-Müllerian hormone, fertilization rate and good-quality cleavage stage embryos rate. Clinical pregnancy and implantation rates were assessed using Fisher's exact test. Results: Ninety-six cycles were selected: 13 from D4, 23 from D3 and 60 from D5. The groups were similar to age (34.5, 36.0 and 33.6 years), body mass index (23.9, 24.7 and 23.1 Kg/m 2 ), anti-Müllerian hormone (2.3, 1.5 and 1.8 ng/ml), fertilization rate (78.4%, 67.2% and 76.2%) and good-quality cleavage stage embryo rate (51.2%, 50.0% and 47.5%). Clinical pregnancy (46.2%, 34.8% and 55.0%) and implantation (34.6%, 25.0% and 39.2%) rates had no statistical difference. Clinical pregnancy and implantation rates were comparable between the groups. Conclusion: Data suggests a trend of better rates on blastocyst embryo transfer, followed by D4 embryo transfer and, finally, cleavage stage embryo transfer, although data is not significant. Embryos in D4 were expected to undergo embryonic genome activation process, helping in selection of embryos to transfer when extended culture to day five is not possible. Our data suggests embryo transfer at day four is a viable alternative and can be recommended. Objective: The use of human blastocyst digital images processing for the extraction of predictive mathematical variables of morphological quality that, associated with embryonic morphokinetic variables, were applied in a software that predicts with high accuracy the potential for live birth. Methods: About one thousand digital images, provided by the IVI Valencia (Spain) and Weill Cornell Medicine (USA) clinics obtained by time-lapse system (EmbryoScope), were standardized and segmented for variable extraction, using algorithms developed on the MatLab ® platform. Morphokinetic information was used in isolation or together relating cleavage times. These morphological and morphokinetic parameters were applied to the input variables of the evaluated software. Results: Eight variables related to morphology were obtained: contrast, correlation, energy, homogeneity, area and eccentricity of the inner cell mass, blastocoel area and blastocyst expansion. The most promising morphokinetic variables in prediction of live birth were: t2, t3, t4, t5, t6, t7 and t8 (time, in hours, from fertilization/insemination to division into two, three, four, five, six, seven and eight cells to be complete, respectively); tSB (time, in hours, onset of blastocyst formation); tB (time, in hours, when the blastocyst is evident); (t3 -t2), CC3 (t5 -t3), RelCC2 (t3 -t2 / t5 -t2 -x100), t4 -t3, tSB -t8 and tB -tSB values. Conclusion: Predictive variables of the morphological quality of the blastocyst associated with variables originating from embryonic morphokinetic resulted in a promising prediction of live birth. 
P-16. Day four embryo transfer:
P-17. Mathematical variables
Methods:
A retrospective cross-sectional study was carried out in which 70 patients were followed up in the IVI Salvador shared egg donation program, where IVF/ICSI cycles were performed from February 2018 to May 2019. Data were analyzed regarding sperm quality, age group of patients, mean number of donated eggs, fertilization rate, embryo quality, number of transferred embryos correlating with clinical pregnancy rate and implantation. Results: Seminal quality was classified as normal in 17.14% of cases, regular in 51.4% and abnormal in 31.4%. The mean age of donors and egg recipients was 31.5 years and 43.9 years, respectively. The mean number of donated eggs was 7.6 ovules and the mean fertilization rate was 75.2%, and 78.5% of the transferred blastocyst embryos were classified as of good quality. Most patients (61.4%) received 2 embryos and the other (38.6%) received 1 embryo. The clinical pregnancy rate was 55.7% and the implantation rate was 42.1%. Conclusion: A good rate of fertilization and embryo quality was obtained, which resulted positively in the clinical gestation rate. Objective: Through the concepts and patterns of human embryonic morfocinetic using the technique of artificial neural networks, sought to find the prediction of the most suitable embryos for transference. Methods: The dataset counted with 9568 information of embryonic divisions, defined as: t2, t3, t4, t5, t6, t7 and t8, times, in hours, from fertilization to division in two, three, four, five, six, seven and eight cells are complete, respectively. We also use the time, the beginning of formation of the blastocyst and the one in which the blastocyst is in evidence. The relations CC2 = t3 -t2; CC3 = t5 -t3; RelCC2 = [(t3 -t2/t5 -t2)]x100; t4 -t3; tSB -t8 and tB -tSB, were also used. These variables present relationships of cleavage times and embryo development, seeking to represent their evolution mathematically. In the same dataset we have the information of birth or not of the transferred embryo, defined as positive or negative liverbirth, respectively. An artificial neural network model was constructed using the information mentioned, seeking an optimal network for the classification of blastocysts in livebirth positive/negative. Results: The results obtained for the training data were 93% for livebirth positive classification and 85% for livebirth negative. For the blind test the result for livebirth negative was 82%, and for livebirth positive 59%.
P-19. Through the morfocinetic data in conjunction with
Conclusion:
The results show that the livebirth positive score for the blind test is still quite challenging, however, for the others, we obtained a very promising assertiveness.
Support:
FAPESP (Processes 2018/19371-2 and 2017/19323-5) . Objective: Analysis of differential gene expression in men with varicocele using RNA sequencing data. Methods: Sperm RNA sequencing data was obtained from a previous study of our research group, a case-control study that included semen samples from men with varicocele (n=6) and fertile men without disease (n=3). Quantification of the number of transcripts was performed by large-scale RNA sequencing (RNA-seq) using the TruSeq SBS kit v5 (Illumina, USA) on Illumina Genome Analyzer IIx equipment (Illumina, USA). The results of this study were using an R programming language, more specific the DESeq2 package and cluster Profiler. For the determination of a differentially expressed gene, the filters of p<0.05 and logFC>1.5 (| logFC |>1.5). Results: Our findings showed that 494 genes were differently expressed between men with varicocele and fertile men without the disease. After data mining, HDCA2 (p=0,0417) and EHMT2 (p=0.0153) genes were less expressed in men with varicocele (logFC = -0.401) when compared to controls (logFC = 0.802). These genes are responsible for important functions associated with self-renewal and germ cell conservation. The alteration in the testicular microenvironment associated with varicocele, caused by thermal and oxidative stress, may be responsible for the genes expression alteration. Conclusions: The HDCA2 and EHMT2 genes, essentials for spermatogenesis process, were less expressed in men with varicocele. Decreased or inhibited expression of these genes may lead to changes in seminal quality in patients with the disease. Results: DNA methylation is the main mechanism that can relate the use of phthalates and BPA to female reproductive disorders. Studies have shown that high levels of BPA were associated with lower numbers of recovered oocytes, mature oocytes from metaphase II, normally fertilized oocytes, low serum levels of E2 and a tendency for less blastocyst formation. Other studies correlate BPA and androgen levels, implying that BPA may play a role in the pathophysiology of PCOS. Phthalates are associated with less ovarian reserve in infertile women, and the literature indicates that it may inhibit the size of the growing array of antral follicles, impairing fertility and fecundity. PFAs appear to be related to parity and may affect steroidogenesis, leading to abnormally high androgens and contributing to the pathogenesis of PCOS. Conclusions: Endocrine disruptors that are present in common substances can affect the females fertility. Therefore, it is necessary for gynecologists to know such properties in order to inform their patients about harmful products and their risks, especially in the area of reproduction.
P-20. Reduced expression of HDAC2 and EHMT2 genes in men
P-21. Analysis of paternal factors and embryo aneuploidy rate
to paternal age: <= 41 years (n=26) and >= 42 years (n=49); sperm concentration in normozoospermic (n=67) and oligospermic (n=8); morphology according to Kruger's strict criteria >=4 (n=17) and <4 (n=58). DNA sperm fragmentation has been assessed in 29 cases. Results: On average, 6.2 MII oocyte were fertilized and 1.9 blastocysts were formed. From 229 biopsied embryos, 143 were normal and 86 altered (37.5%, 79 numerical and 7 structural abnormalities). Advanced paternal age -median of 44.7 years old -and sperm concentration were not related to an increase in the absolute number of embryo aneuploidy (p=0.15 and 0.70, respectively). According to strict morphology, Kruger < 4% had 36% of aneuploidy comparing with 42.5% in Kruger >= 4 (p= 0.38). Sperm DNA fragmentation in a 15% cut-off did not show statistic difference between the groups (p=0.08). Conclusions: Therefore, these results suggested that the paternal factors, including age, sperm concentration, strict morphology and DNA sperm fragmentation were not related to the aneuploidy rate in preimplantation embryos in an oocyte donation program. This cross-sectional study was carried out using a semi-structured electronic questionnaire containing questions elaborated based on the requirements for the manipulation of human gametes and embryos in an ISO Class 5 cleanroom. Results: Of the 46 participating laboratories, 33 (71.7%) reported that they perform microbiological monitoring every six months, while 15.2% performed the tests once a year. Regarding the types of microbiological tests, the laboratories reported the use of contact plates (69.5%), swabs (63%), and settle plates (34.8%). The monitored environments most frequently cited were the interior of the vertical CO2 incubator (97.8%), the laminar flow cabinet (93.5%) and the air from the embryology laboratory (91.3%). Only 67.4% of the respondents (31/46) sampled the micromanipulator, considered a critical area. No consensus was observed regarding the number and location of sampling sites or ideal period to perform microbiological tests (activity 41.3%, rest 37%, both 21.7%). The occurrence of microbiological contamination of IVF cultures was reported by 26.1% of the laboratories. Conclusion: Taken together, the data obtained from the responses by the embryologists points to the existence of many gaps in the practice of microbiological monitoring, including: lack of consistency in the sampling procedures (critical areas to be monitored, representative sampling points, ideal methods and period of time) among different clinics, and the lack of clear and definitive guidelines that address the different sources of microbiological contamination, the need for routine monitoring and specifications for its execution. Objectives: The aim of this study is to investigate how cancer in the female genital tract can influence female fertility and seek to know about the most used methods for preserving fertility. Methods: Integrative review of the literature on the subject, based on articles from the last fourteen years. It was used as a database: Scielo and PubMed. Researched during the period from January 2019 to May 2019. Results: The therapies used to treat oncological diseases, chemotherapy and radiotherapy, involve cytotoxic drugs with a high germ cell lesion, especially ovules. Prior to the definitive treatment of the disease, embryo cryopreservation, oocytes, ovarian tissue, suppression of ovarian function and ovarian transposition were used in order to preserve fertility. One of the non-surgical options, hormone therapy, may be considered for women with low-grade endometrial cancer at an early stage. In addition, one should always try, when the treatment is surgical, to perform the fertility-sparing surgery, such as conization.
P-
P-24. Fertility in patients with
Conclusion: Treatment for cancer in the female reproductive system has consequences for the woman, but in some cases it is possible to perform the control, always aiming at the care of the patient as a whole, respecting their wishes and their dreams. A considerable number of patients who are affected by a neoplastic disease will survive it and may manifest reproductive desire in the future, so the importance of this subject will be studied more and more deeply. The Information was collected through the application of a questionnaire about main comorbities and diseases that may interfere with the reproductive status of the male participants. Results: Men studied had between 30 and 54 years old (average 39), with the majority of Causasian participants (94%). Among the analyzed comorbities, high cholesterol levels are what most affects this group of patients (13.21%), followed by dermatitis (11.32%) and tabagism (9.43%). In relation to the comorbities recognized and handled by the patients stand out heart and lung diseases, diabetes and epilepsy. When considering reproductive health, mumps (16.98%) and varicocele (15.09%) were prevalent, although these were the diseases with lowest treatment indexes (22.22% and 25%, respectively).
Conclusion:
The profile analyzed through this study brings together factors that are known to interfere with sperm concentration and quality, which are often disregarded in the evaluation of male fertility. Research and identification of these comorbities may be relevant when it is intended to improve the conditions of male reproductive health. Comorbities identification and further treatment prior to performing assisted reproductive cycles can result in higher success rates, optimizing in vitro fertilization treatments. Objective: To present the judicial updates, in the tangent of post-mortem fertilization, of Brazil in relation to developed countries regarding the characteristics and the ethical aspects of the subject.
P-26. Post-mortem Fertilization -How is the judicialization
Methods: Bibliographic review of the topic, using a sample of 9 articles published between 2009-2017, indexed in the SCIELO, LILACS, BVS and PubMed databases, in English, Portuguese and Spanish, and selected according to the "classification of relevance "of these bases. Results: Judicial authorization for sperm acquisition with intentional post-mortem fertilization is still a debatable issue, since each country has its own specific legislation. Several ethical factors are considered, such as the express authorization of the deceased party. In the Netherlands, Spain, Canada and Brazil (through Law nº 1.957 / 2010 of the Resolution of the Federal Medical Council), this technique is only allowed with this consent of the donor. In Belgium and the UK this is not necessary. In addition, in some countries such as Canada, fertilization is only allowed after a period of 6-12 months, allowing the family to consider all the implications of that decision. However, the Brazilian legislation does not define a period for carrying out the procedure. Conclusion: Post-mortem fertilization is still considered taboo in Brazilian legislation, and it is difficult to defer the plausible ethical limits of this theme. However, it is necessary to define more criteria to judge this issue, such as the adequate time after the death to occur fertilization and a suitable psychiatric analysis of the individual who will use the genetic material to avoid precipitated measures. Objective: Conventional karyotyping is the gold standard for chromosomal investigations of products of conception (POC). However, it is vulnerable to selective overgrowth of maternally derived cells, falsely producing a finding of normal female karyotype at rates of 29% to 89.7%. Our group has shown POC by next generation sequencing (NGS) combined with Short Tandem Repeat (STRs) for fingerprinting analysis of maternal cell contamination (MCC) is faster and can detect some abnormalities not possible with conventional karyotyping because of contamination, number of cells and resolution. AIM: To evaluate and describe chromosomal abnormalities in POC by NGS + STRs techniques. Methods: 225 first and 10 second trimester miscarriage specimens plus patient´s blood were received between January 2017 and December 2018 at our laboratory. We performed NGS (Thermo Fisher ® ) plus STRs analysis to detect chromosomal abnormalities and discard MCC. Results: Given the specimens from first trimester, 58.2% had abnormal results (42.6% with trisomies and 5.3% with monosomies; 8% were polyploid or triploid and 2.2% contained structural chromosome abnormalities) and 23% were normal (XX or XY). Only 17.3% had MCC and 1.3% were not evaluated because of their quality. Regarding the second trimester specimens, 40% had abnormal results (trisomy 18, triploidy and partial deletion of the chromosome 4), 50% were normal (XX or XY) and one sample presented MCC. Conclusion: With NGS and STRs tissue origin could be determined when the result was normal so maternal contamination results were notably reduced in first and second trimester (< 20%) when compared to the traditional analysis. P-28. Transfer of one euploid blastocyst embryo versus two non analysed blastocyst embryos: Preganancy and abortion rate influence Objective: To determine if the transfer of only one euploide embryo after thawing generates higher pregnancy rate when compared to transfer of 2 non analyzed blastocysts after thawing, in 2 different age groups. Methods: Pregnancy and abortion rates were analyzed in 164 cycles where one euploid embryo was transferred following thaw and 317 cycles where two blastocysts embryos were transferred following thaw without biopsy. The patients were divided in two groups: <38 years and >38 years, chi-square test was used and the Fisher exact test (p<0.05) using BioEstat 5.3 program. Results: The group of patients <38 years were performed 132 cycles with a transfer of only one euploid embryo, it was observed 49% pregnancy rate and 6% abortion rate. In this same group, the patients that transferred two thawed blatocysts, the pregnancy rate and abortion rate were 55% and 12%, respectively (p=0,3108; p=0.274). When patients with > 38 years were compared the pregnancy rates for the transfer of one euploid embryo versus 2 non analyzed embryos were 72% and 47 % (p=0.0279) and the abortion rate were 10% and e 8% (p=0.995) respectively. Conclusions: It was observed that patients with age >38 years, that transferred embryos biopsied increased significative the pregnancy rate/transfer. However for the group <38 years, the genetic analysis did not affect pregnancy and abortion rates, therefore the use of PGT for this group is not indicated, avoiding any risk of manipulating the embryos during the biopsy procedure. Objective: To investigate the influence of the supplementation of antioxidant (AX) coupled with different classes of lipids (LIPID) and/or phospholipids (PL) on the cryotolerance, survival, in vitro embryo development, and mitochondrial activity of oocytes vitrified in Tvitri-4 standard medium (T4 -Invitra Tecnologia da Reprodução Assistida Ltda.) Methods: In this experimental study, in vivo matured oocytes of C57BL/6 mice were distributed in 5 groups: fresh control (CT) and vitrified: T4 (control), T4-AX, T4-LIPID and T4-PL. After vitrification and thaw, we analyzed oocyte survival. Viable oocytes were fertilized in vitro or used for analysis mitochondrial activity markers (15 oocytes per group): reactive oxygen species (ROS), oxidative metabolism, and mitochondrial membrane potential (JC-1). Oocytes from the 5 groups submitted to IVF were cultured for 96h and subsequently compared in terms of fertilization/ blastocyst formation, total number of nuclei (NT) and internal cell mass (ICM)/trophectoderm cells (TC). Results: The survival rate of oocytes vitrified in T4 was higher than the T4-AX, T4-LIPID and T4-PL (100%, 97.07%, 96.75% and 97.95%, respectively). The number of MCI cells in CT group embryos was higher than in T4 and T4-AX, and similar to T4-LIPID and T4-PL (p>0.05). Mitochondrial integrity and density (JC-1) was similar in oocytes from the CT, T4-LIPID and T4-PL groups. Conclusio:n Analysis of the MCI number and mitochondrial function outcomes suggests that the prospective lipid/antioxidant formulation improves oocyte cryotolerance Objective: To determine risk factors for poor ovarian response (POR) to controlled stimulation in assisted reproduction cycles and to describe the outcomes of this specific interest group. Methods: This is an observational retrospective study comparing 108 in vitro fertilization cycles from a POR group (< 4 oocytes retrieved) to 61 cycles from a control group (≥ 10 oocytes retrieved). All the cases came from a two-year period (2015) (2016) and where conducted in a single quaternary center in Brazil. Results: The POR group was older than the control group (mean age POR group 36.55±2.67 vs. 34.56 ±3.15 in the control group, p<0,001) and had a lower antral follicle count (mean 7.19±5.99 vs. 13.10±5.07, p<0,001). The POR group had shorter cycles, lower estradiol levels on the triggering day and thinner endometrium. They've had formed fewer embryos and most of the transfers of the POR group where done in cleavage stage compared to the control group, whose where mostly day-5 transfers. The POR group had lower clinical pregnancy rates from fresh transfers when compared to control group (p<0,001). Conclusions: Age and ovarian reserve are associated with the response to ovarian stimulation. The oocyte recovery rate has a direct impact in IVF treatment success. Objective: To evaluate the initial results of oocytes accumulation for patients with low ovarian reserve and patients with a low number of embryos to transfer in a previous cycle of in vitro fertilization without success. Methods: The patients from Humana M.R. who opted for accumulation of eggs between April 2016 and May 2019 were evaluated. These patients were divided into two groups: Group 1 (26 patients aged 39 years) and Group 2 (17 patients between 40 and 42 years). It was evaluated the average of the antral follicles, the average number of collections per patient, the average number of ovules MII per patient, survival rate of MII eggs after devitrification, fertilization rate, percentage of embryos with ≥6 blastomeres in D3, chemical pregnancy rate when embryos was transferred with ≥6 blastomeres in D3, chemical pregnancy rate by ITT(treatment Intention = 2 egg collections with at least 1 frozen MII), evolution gestation for ITT rates and non-transfer rate. and embryo quality. Mitochondrial integrity was preserved in oocytes treated with antioxidants, lipids and/or phospholipids during cryopreservation, and β-oxidation was stimulated in T4-LIPID oocytes. Methods: This is a retrospective cohort study performed in the period between June -December 2017. The study included 598 embryo transfers in ICSI cycles, with fresh and frozen embryo transfer (FET) cycles (n=299 with AH; n=299 without AH), and with cleavage and blastocyst stage transfers. We included patients that performed the ICSI cycle with their own oocytes and also oocyte donation. Due to the heterogeneity of the group a multivariable analysis was performed using Logistic regression in which the effect of AH on ongoing pregnancy was calculated considering maternal age, oocyte origin (donated or own), embryo developmental stage, number of embryos transferred and the proportion of good quality embryos transferred as potential bias factors. The effect of AH was calculated with its corresponding odds ratio (OR) and the 95% Confidence Interval (CI) together with the OR of the potential bias variables. The statistical analysis was performed by using SPSS 26 software. Results: We observed that the empirical use of AH is not independently associated with ongoing pregnancy rates in ICSI cycles neither in fresh nor FET cycles (OR=0.942; 95% CI: 0.645-1.376). Conclusion: Our results suggest that there is still a lack of evidence to show in which group of patients AH would improve clinical outcomes. The overall use of AH does not improve clinical outcomes and may increase embryologist workload and embryo manipulation without any advantage. Objectives: To evaluate the influence of blastomere symmetry at day 3 on blastocysts quality and biochemical pregnancy rate. Methods: A cohort of 221 patients with blastocyst transfer from 2010 to 2019 at the Insemine Human Reproduction Center. Age, cause, AMH, FSH, number of recovered oocytes, number of MII, fertilization rate, embryo quality at day 3 and day 5 and blastomere symmetry between positive BhCG and negative BhCG groups were compared. Results: The variables symmetry and embryonic quality at day 5 were statistically significant (p=0.027 and p=0.0001) between positive BhCG and negative BhCG groups. As well as the influence of symmetry in embryo quality at day 5 (p=0.032). A multivariate analysis controlling the pregnancy variable for symmetry and quality in D5 demonstrated independence and association with the outcome (p=0.032 and p=0.001). The analyzes of NNT between symmetry and pregnancy, quality at day 5 and pregnancy, symmetry and quality at day 5, respective values were obtained: 4.4 (95% CI 16.7 to 2.53), 3.4 (95% CI 6.36 to 2.32) and 6.67 ( 95% CI 3.26 to ∞).
P-27. Chromosomal abnormalities analysed by NGS platform + STRS in products of conception
P-31. FIV/ICSI -Initial results of oocytes accumulation in our clinic
Results
P-32. Empirical use of Assisted
P-33. Influence of blastomere
Conclusion:
The blastomere asymmetry at day 3 affects negatively the blastocysts quality, as well as the biochemical pregnancy rate. Patients with asymmetric embryos who developed good quality blastocysts are 6 times more likely to have negative biochemical gestation compared to patients who had good blastocysts from symmetric embryos. Objective: Carrier screening test identifies autosomal recessive (AR) and X-linked mutations in individuals. Nowadays, it is becoming a standard practice for individuals with a positive family history of a recessive disease (RD) but few studies evaluated risks and the frequency for multiple single-gene disorders among Brazilian asymptomatic individuals. AIM: To evaluate the frequency of AR mutations obtained in our carrier screening tests (CGT600 by Igenomix ® ) for Brazilian patients (couples in reproduction treatments, egg donors, consanguineous). Methods: Retrospective study. 268 adults with or without familiar history who underwent CGT600 tests between 2015-2019 at our centre were enrolled. Results: 238 (88.05%) patients had no family history of rare disease and given the ethnicity, the majority was Caucasian (72.8%), followed by Latin (23.1%), Ashkenazi (2.2%), Arabian (0.75%), African (0.4%) and others (0.75%). About results, in the total 223 mutations were detected. Regarding the conditions: Caucasian were positive for Alpha-thalassemia (N=11) and Spinal muscular atrophy (N=8), Latin were Cystic fibrosis (N=5) and Alpha-thalassemia (N=4), Ashkenazi was Non-classic congenital adrenal hyperplasia (N=2), Arabian were Classic congenital adrenal hyperplasia (N=1) and Non-classic congenital adrenal hyperplasia (N=1), African was Retinitis pigmentosa type 43 (N=1).
P-34. Frequency of findings in
Conclusion:
The study shows the frequency of carriers of autosomal recessive disorders in Brazilian population is similar results to reported data using the same panel for different population. To prevent rare diseases prior to pregnancy, carrier testing may be suggested to patients and those with a positive may consider an IVF treatment plus PGD for monogenic diseases or gamete donation. 1 , A.C.A. Mancebo 1 , A.L.O. Barbeitas 1 ,  R.A. Antunes 1 , P.C.F. Areas 1 , M.C .52 x 2080.45±852.36 (p=0.0008), number of oocytes 3.00±2.11 x 3.69±2.20 (p=0.02) and Metaphase II retrieved 2.20±1.64 x 2.99±1.88 (p=0.02) were significantly different, the ratio of total oocytes /mature follicle ≥15mm (0.93 x 0.98) and Metaphase II oocytes/ mature follicle ≥15mm (0.68 x 0.79) were similar in both groups. Oocyte pick up failure occurred in 16% x 9.8%. Conclusion: Considering that there were no differences in the oocyte per follicle ratio, the follicle flushing didn´t improve the number of oocytes retrieved in poor responders in our study. Mature oocytes: group 1: 70%; group 2: 69% and group 3: 69% (p = 0.05). ICSI fertilization rate: group 1: 81%; group 2: 70% and group 3: 71.8% (p>0.05). Rate of blastocysts: 53.3% group 1; 62.4% group 2 and 62.8% group 3 (p>0.05). Clinical pregnancy rate: 50% (5/10) group 1; 43.7% (7/16) group 2 and 59.7% (49/82) group 3 (p=0.32). Abortion rate: 0% in group 1; 14.3% group 2 and 22% group 3 (p=0.36). Multiple pregnancy rate: 0% in groups 1 and 2 and 25% (7/35) in group 3 (p=0.136). Conclusion: Blastocyst transfer in patients up to age 38 helps to select the embryo to transfer, minimizing risks of multiple gestation, without significantly affecting baby's home rate. Although N is not significant, these data help convince couples of single blastocyst transfer, since the difference in single to double transfer pregnancy rate is not significant, with negligible risk of multiples. Objective: To identify the main reasons referred by men to be donors of semen; knowing the psychological profile of donors; provide grants for staff to work more effectively and integrated with men who are candidates for donation. Method: January 2008 to December 2013 men were approved to be semen donors. Along with the physical assessment questionnaire, the candidate answered some subjective questions. Results: Eighty-three men were accepted for donation, the average age was 26 years old; 67% were single; attending university degree 40%; white people 66% and 70% without children until the moment of donation. According to the donors' perception about them who would receive his donation 22% thought they would be happier to receive their donation. Fifty-two percent consider themselves happy/kind/calm. Regarding the motivation to donate -help patient known (discount on treatment) were 22% and help woman/couple (unknown)55%, the others, 23%, interested in "perpetuating the species". Conclusion: Narcissistic questions appeared as motivation to donate; in addition, the data indicate that altruism is the main motivation. When we consider the emotions, we know that "part of self donated to the other" involves many questions beyond pure altruism and that vehement dedication to the other carries within itself strong symbolic value.
P-35. Double versus single lumen needle: Still worth this question?
M.M. de Souza
P-36. Single embryo transfer: Comparison between single x double transfer of blastocysts
P-37. Relation between the morphology of the spermatozoa
Objective: The objective of this study was to relate the morphological defects of spermatozoa heads with the flagellum edema class after the hyposmotic test (HOST). Methods: Human seminal samples (N=11) were submitted to a hyposmotic solution in the proportion 1:1 during 5 minutes at 37°C. Posteriorly was performed smear and slides were stained with Quick Panoptic Kit (Laborclin ® ). In optical microscope (1000x) was performed and classified (N=200) the morphological defects of spermatozoa head and relationed with the types of flagellum edema (A-G) according to the World Health Organization. Results: The spermatozoa with flagellum edema in the hyposmotic test of type 'D', followed of the type 'C', showed more normal morphological rate, being respectively 33% and 23%, and the spermatozoa with flagellum edema of type 'G' presented the less normal spermatozoa rate (12%), being the defect amorphous the biggest prevalence at the spermatozoa type 'G' (rate of 28%), while the spermatozoa type 'C' and 'D' showed respectively rates of the 20% and 15% amorphous. Conclusion: It was observed that the spermatozoa with flagellum edema classified as 'C' and 'D' are the ones with the best head morphology in comparison with those of class 'G', which may be a selection criterion for intracytoplasmic sperm injection (ICSI), accomplished after the hyposmotic test (HOST). Objective: To identify parameters that characterise the fertilization faillure occurence. Methods: The cases of fertilization faillure between january 2010 and april 2019 (n=139) and the cases without fertilization failure (n=424) composse the sample.
P-39. Follicular output rate e motilidade espermática pós-processamento estão relacionados
Results:
Couples' ages were not diferente between groups: 37 years old [33] [34] [35] [36] [37] [38] [39] [40] and 36 years old [33] [34] [35] [36] [37] [38] [39] [40] for women and 38 years old [34] [35] [36] [37] [38] [39] [40] [41] [42] and 37 years old [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] for men in study group and control group, respectively, as well as serum levels of anti-Müllerian hormone. Serum levels of follicle stimulating hormone are reduced in the fertilization failure group, 6.40 UI/mL [4.23-9.50] in comparison to the control group, 7.20 UI/mL [5.90-9.27] (p=0.04). The Follicular Output RaTe (FORT) for the study group was 58.54%±6.38% and for the control group was 86.41%±3.72% (p=0.001). The retrieved oocyte number, 2 [1-5] and 5 [3-8] (p = 0.0001) and mature oocyte number, 2 [1-3] and 5 [2-7] (p=0.0001) for study and control group, respectively, presented the same pattern. Seminal volume, pre and post-processing spermatic concentration and pre-processing spermatic motility did not revealed statistical diferences between groups. However, post-processing spermatic motility for study group was 80 million/mL [70-90] and for control group was 90 million/ mL [80-95] (p = 0.0001). Linear regression resulted in a statisticallly significant model [F(6,67) 
Departamento de Ginecologia e Obstetrícia -Faculdade de Medicina-Universidade de São Paulo -Ribeirão Preto-Brazil
Objective: This study aimed to evaluate the effects of in vitro follicular development on oxidative metabolism, on the generation of cellular oxidative stress and levels of genes. Methods: Three-dimensional in vitro culture of bovine secondary follicles was carried out for 16 days in supplemented α-MEM medium, in an atmosphere of 5% CO 2 and 20% O 2 . As controls two groups of fresh follicles were included. Were performed morphological, analy- Objective: to correlate serum thyroid stimulating hormone (TSH) level with ovarian reserve and pregnancy rate. Methods: A prospective study was conducted with 242 infertile patients undergoing in vitro fertilisation, without previous diagnosis of hypothyroidism. Thyroid function was evaluated through serum TSH. Patients were selected from January 2017 to December 2018, in a single human reproduction center. Serum antimullerian hormone (AMH) and antral follicle count (AFC) were performed to evaluate ovarian reserve. Serum dosage of human chorionic gonadotropin (beta-HCG) was used as a reproductive outcome, characterizing biochemical pregnancy if positive. Results: The mean age was 35.9 years old (SD±4.44) and serum TSH mean was of 2.07 mU/L (SD±1.08). Biochemical pregnancy rate was 35.8%. There were no correlation between TSH and AMH levels (r= -0.13, p=0.866) and AFC (r=0.02, p = 0.981), even as no association between biochemical pregnancy rate and TSH levels p=0.763) . Conclusion: in this particular population of women with good thyroid function control measured by TSH, there was no correlation between serum TSH levels with the ovarian reserve measured by AMH or AFC, as with the reproductive outcome evaluated by the biochemical pregnancy rate. Methods: 235 patients with RIF who underwent ERA test and submitted to hormone replacement therapy (HRT) (average progesterone= 119 hours) between 2015-2018 at our centre in Brazil were enrolled. Patients were stratified by age in five groups and their endometrial receptivity status was assessed by ERA computational predictor. Results were divided in 2 main groups: receptive ® (including early and late receptive) or non-receptive (NR) (pre and post receptive). Data were analyzed comparing groups with Kruskal-Wallis test and considered statically significant when p≤0.05. Results: Regarding the receptive results, a slight decrease in percentage rate was observed with increasing maternal age (58.8% in women <35 years; followed by 52.6%; 50.9%, 56.8% and 37.9% in ≥44years). In the non-receptive (NR) category, a little increase in percentage rate with advancing maternal age was detected (41,18 % in women <35 years, followed by 42.27%, 49.1 %, 43.18% and 62.07% in women ≥44years), although results were not statically significant (p=0,15). sis RT-qPCR expression of target genes, quantification of intracellular reactive oxygen species and the redox state evaluation of the mitochondria and the oocyte cytoplasm. Results: In this study a reduced production of reactive oxygen species was observed in oocytes from follicles cultured in vitro in relation to oocytes obtained from the control groups: fresh secondary follicles (p<0.0065) and in vivo partially matured pre-antral follicles (p<0.001). However, it was observed that the oxidative metabolismo redox status of the mitochondria and the cytoplasm of oocytes obtained from in vitro culture was higher when compared to controls (p>0.05). Analysis of mRNA expression in oocyte and in follicular somatic cells showed a significant decrease in the relative quantification of Kit Ligand in the cultured follicle when compared to controls (p=0.03). Conclusion: Although there was an increase in redox status in oocytes, the system was efficient in controlling the production of the reactive oxygen species during cell metabolism. The Kit Ligand gene expression indicated damage in the communication betweenfollicular somatic cells and the oocyte. Objective: To investigate the effect of perfume on embryo development in vitro. Methods: A total of 162 murine embryos from B6D2F1 females (C57BL/6 X DBA/2) were used. The 2-cell embryos were cultured (20µL) in GV-Blast medium (Ingámed ® ) supplemented with 10% Soro Ingámed (Ingámed ® ) and divided into 6 groups: Control 1 (C1)-cultured without exposure to the perfume and kept inside the incubator (n=21); Control 2 (C2)-cultured without exposure to the perfume and kept daily outside the incubator (n=21); T1cultured on plates with scent brushed on the internal part of lids (10µL) 1 hour before exposure (n=30); T2-cultured on plates with scent brushed on the internal part of lids (10µL) 6 hours before exposure (n = 30); T3-cultured on plates with scent brushed on the internal part of lids (10 µL) 24 hours before exposure (n=30); T4-grown on fragrance-free plates daily handled by a person using perfume (20µL) applied one hour earlier (n=30). Groups C2 and T4 remained outside the incubator daily for 10 minutes under heated plate laminar flow (37°C). Results: Groups C1, C2, T1, T2, T3 and T4 presented blastocyst rates of 95%, 100%, 100%, 97%, 97%, 97%, respectively, and hatching rates 60%, 57%, 57%, 41%, 59% and 62%, respectively. Conclusion: The application of perfume (10µL) in the culture plates and used by a person (20µL) that manipulates the embryos outside the incubator daily did not interfere in the rates of blastocyst formation, although the T2 group showed a decrease in the hatching.
P-41. Correlation of TSH levels with ovarian reserve and reproductive outcomes in women un
P-42. Can the use of perfume
Conclusion:
Our results showed women with a history of RIF presented a displacement in the window of implantation and consequently a non-receptive endometrium, showing no relationship with maternal age and demonstrating the importance of the study of endometrial factor in these cases. Objective: Endometriosis is associated with infertility; however, the exact mechanism is unclear and embryo development could be one of the factors involved. Our objective is to evaluate the embryo quality on Day 3 and 5 and symmetry on Day 3 in women with and without endometriosis undergoing in vitro fertilization. Methods: It was a retrospective study with 221 patients and 1308 embryos. Inclusion criteria were women with infertility and indication of IVF/ ICSI who had at least 1 embryo Day 5 for fresh transfer. They were divided in two groups: with and without endometriosis. Statistic analysis was performed with SPSS, T-student test was used for parametric variables and qui-square for categorical variables. The significance threshold was set at 0.05 for P-value. Results: The group with endometriosis had 47 patients (21.3%), and the group without endometriosis had 174 patients (78.7%). There was no diference of age (media 33.89 vs 35.05, P 0.138), oocyte number (media 9.02 vs 9.35, P 0.605), MII number (media 8.36 vs 8.08, P 0.613) or number of embryo transfer (1.96 vs 1.99, P 0.251) between the groups with and without the disease, respectively. In relation to embryo quality on Day 3, symmetry on Day 3 and quality on Day 5, also there was no statistical difference (P 0.470, P 1.000, P 0.431, respectively). Conclusion: There was no difference in quality and symmetry of embryos in women with and without endometriosis undergoing IVF, according most recent studies about the fertility impact of endometriosis. Introduction: The examination method of choice for the investigation of infertility caused by uterus and fallopian tube abnormalities is the histerosalpingrography. It's considered a safe and easy method with a low complication's rate. Although, when facing adverse events, serious and even fatal endings can occur, one of then is the uterine perforation. In the presente study, a case of a fallopian tube disruption due to the exam is analised.
P-44. Embryo symmetry in wom-
P-45. Tubal perforation due to hysterosalpingography: a case report
Caso report: A 40-year-old female patient underwent HSG for infertility investigation on May 9th, 2019 in the city of Francisco Beltrão, Paraná. Soon after the procedure, which was reported as painful, the patient started a severe pain in the hypogastric region, evolving with constant pain but with lower intensity on subsequent days. He used anti-inflammatories and other analgesics in order to ease the pain, without success. On May 18th, there was intensification of hypogastric pain associated with tachypnea. Patient said got worse during the course of the day and was reported as unbearable late in the afternoon, prompting her to seek medical help. At admission to the emergency room at the Hospital São Francisco, she had severe pain in the hypogastric area associated with dyspnea, asthenia, inability to remain in the orthostatic position, sweating and cold skin. Upon physical examination, the patient was hypocorate, desaturated, gout, hypotensive, tachypneic, apathetic, with chills, axillary temperature of 36.5 o C and blood pressure of 90x60 mmHg. To investigate the cause of hypotension, a computed tomography (CT) scan of the abdomen was performed, which showed moderate to large amounts of fluid in the abdominal cavity, suggesting that the acute abdomen was hemoperitoneal due to rupture of viscera. She was sent to the surgical center for unilateral salpingectomy and exploratory laparotomy, where hemoperitoneum and pelvic abscess were observed. On May 19th, due to the maintenance of signs of hypotension and hyposaturation, she was transferred to the intensive care unit, where vasoactive drugs, blood transfusion and volume resuscitation were administered, as well as orotracheal intubation to correct the observed desaturation. On 05/20, the patient was hemodynamically stable. On subsequent days, she presented clinical improvement, pulmonary improvement and reduction of hemoperitoneum, demonstrated in abdominal CT .On 05/23, she developed cerebral edema, causing unresponsive ocular opening and global motor deficit. On May 25th, he presented pneumothorax associated with partial collapse of the lung. After management of the condition, the patient presented clinical improvement and was transferred to the hospital bed for motor and pulmonary recovery. Currently, on May 31st, the only symptom referred is dyspnea. Comments: HSG is a widely used method for assessing infertility because of its low cost, ease and practicality. Despite their importance, the number of studies and reviews published in recent years that address their complications is too limited. The case report addresses a tubal rupture event due to HSG, in which immediate intervention was necessary to correct the alterations at the genital and systemic level. In this context, the clinical case reinforces the need for medical class knowledge about HSG. Therefore, it is essential that more studies are conducted addressing adverse events, even infrequent ones, as well as their management. . Comparing G1 vs. G3: oocytes aspirated (p<0,001), mature (p<0.001), oocyte maturation rate (p=0.04). A weak negative correlation was found between mature oocytes vs. BMI (r = -0,214; p<0.001) and oocyte maturation rate (r = -0.126; p=0.029). Conclusion: Comparing normal BMI and obesity, there is a statistically significant decrease of aspirated and mature oocytes, suggesting lower response to ovarian stimulation in obesity. In addition, the negative correlation found corroborates the hypothesis that obesity has negative impact on ovarian stimulation after IVF. Objective: State of the art vitrification techniques opened possibilities in IVF, allowing think ovarian stimulation and endometrium preparation separately. Two variables could be rethought: suppression of LH surge and phase of stimulation. It is known that synthetic progestins are effective suppressors of LH surge, but previously not used for this purpose due to endometrial effect. Recently, some authors proposed a progestin primed ovarian stimulation as an alternative to suppress the LH. Progestins have advantages of being oral, inexpensive and accessible, but concerns remain about quality/quantity of oocytes. As embryos will not be transferred, another advantage is starting stimulation according to follicular waves. Methods: In this retrospective cohort study, we recruited all patients submitted to progestin primed ovarian stimulation (PPOS) between January and December 2017 and followed them until embryo transfer, if applicable. There was no loss of follow up for the main outcome. After providing informed consent, we obtained 100 cycles from 79 patients who were divided in two groups according to the phase of menstrual cycle that they initiated treatment. Matching criteria were patients who underwent PPOS treatments at VidaBemVinda Clinic in 2017. The follicular phase group had 32 subjects and 39 cycles and the luteal phase group had 47 subjects and 61 cycles. Both groups were homogenous for age, BMI, smoking habits, time and causes of infertility and ovarian reserve tests (FSH, AFC and AMH). The assays were performed using R 1 ANDROFERT -Centro de Referência para Reprodução Masculina -Campinas -SP Objective: Pregnancy failure after euploid blastocysts transfer reinforces the involvement of multiple factors in embryo implantation. Recent studies suggest that blastocysts with a high number of mitochondrial DNA copies (mtDNA) have a lower implantation potential, but there is no consensus. This study aimed to determine the predictive value of mtDNA in euploid blastocysts implantation potential. Methods: The mtDNA was quantified in 125 euploid blastocysts, previously submitted to new generation sequencing (NGS). A score based on mitochondrial DNA / genomic DNA ratio (Low-Intermediate-High) was applied. Only single euploid blastocyst transfer cycles were included. Results: Among blastocysts with a High score (n=17), 4 (23.5%) resulted in ongoing pregnancy. On the other hand, the rates for euploid blastocysts with Low-score (n=82) and Intermediate (n=26) were 51.2% (42/82) and 50.0% (13/26), respectively (p=0.0399). Logistic regression showed that trophectoderm quality (Exp (B) = 0.425, p=0.023) and mtDNA (Exp (B) = 3.596, p=0.042) were predictors of implantation. The positive predictive value of the ongoing pregnancy rate was 64.2% and the negative predictive value was 72.4%, with sensitivity of 72.9% and specificity of 63.6%. Conclusion: Regardless of the mechanism that explains the non-intuitive deleterious effects of excess mtDNA, a combination of high-accuracy measurement technique, adequate data adjustment and the establishment of a score seem critical in determining mtDNA role as a valid biomarker. Objective: To assess the influence of Body Mass Index (BMI) and age in the ovarian response, fertilization rate, embryo development rate and pregnancy rate of patients who undergo IVF treatments. Methods: Data from 966 patients who underwent IVF treatment from January 2013 to March 2019 were analyzed. Patients were categorized according to BMI in groups 1 to 4 (Underweight, Normal weight, Overweight and Obesity) and age in groups A, B and C (18-34 years old, 35-39 years old and over 40 years old). BMI and age impact were analyzed both separately and together. Results: Group 2 presented higher number of oocytes retrieved and lower fertilization rate than group 4, and higher cleavage rate than group 3. Group A had more oocytes and better pregnancy rate than groups B and C, and lower cleavage and embryo development rates than group B. Group A2 had a higher number of oocytes than group A4 and higher cleavage rates than group A3. Group B showed no statistical difference amongst the BMI groups for the assessed parameters. Group C4 had less oocytes comparing to the other BMI groups, and lower pregnancy rate than groups C1 and C2. Conclusion: Overall, a higher BMI is associated with a lower number of oocytes retrieved and cleavage rate. The fertilization rate remain comparable between the groups, when analyzing both BMI and age. Specially in women over 40 years old, weight influences the outcomes of number of oocytes retrieved and pregnancy rates. Objective: Evaluate if the dosage of AMH has a quantitative relationship with the number of eggs aspirated in different age groups. Methods: A total of 733 patients were analyzed between 2014 and 2019, divided into 2 groups of AMH values: <1.2 and >1.2. and by age group: ≤35 years, 36 to 39 years and ≥40 years. The number of retrieved eggs in each group and the number of eggs per age group within each group were compared. Results: The mean number of retrieved eggs in each group of AMH was, respectively, 3±3,1 and 10±6,8, (p=<0,0001). When comparing the number of retrieved eggs per age group, we found respectively for the group <1.2: 5±3.81, 3±2.78 and 2±2.4 and for the group >1.2: 11±7.7, 9±5.8 and 9±6.1. Showing significance among all age groups among the AMH groups. It was also significant when we compared the mean value of AMH dosage by age groups (p=<0.0001). Conclusion: Collaborating with the literature, AMH can be used as an efficient biomarker to determine, in addition to the ovarian reserve, the expected number of eggs in IVF treatments, therefore, women with AMH >1.2 have a significantly higher number of eggs aspirated per procedure and that maternal age, directly linked to the value of AMH, has an influence on the number of aspirated eggs. P-56. Efficiency of obtaining blastocysts in different age groups and pregnancy rate V.B. Rosa 1 , B.C.V. Campos 1 , A. Schuffner 1 software 3.5.1 and a 5% significance level was considered. Results: The mean number of oocytes collected was 7.9 (SD:5.7) in follicular phase group versus 9.6 (SD:5.7) in luteal phase. Although the absolute numbers were higher there was no statistically significant difference between groups (p=0.21). We also noticed that in the luteal phase group, the duration of stimulation (11.3 vs 12.2 days p=0.04) and dose of FSH were significantly higher (2718 U vs 2233 U p=0.001). The blastulation rate was also slightly better in the luteal phase group ( 24.2% x 35.7% p=0.046) , but the mean clinical pregnancy rate was similar between groups (54.2% x 51.7% p=0.9). Conclusion: The use of follicular/luteal phase progestin primed ovarian stimulation is simple, inexpensive and flexible. This protocol could be used in almost all IVF/ICSI cycles, from poor responders to oocyte donation and fertility preservation. Luteal phase could possibly have better ovarian response, however the difference was not statistically significant in this study. the rate of pragnancy, further influencing embryonic aneuploidies. The objective of this study was to correlate the total dose of gonadotropins used with the number of euploid embryos after biopsy. Methods: A total of 203 patients were analyzed between February 2012 and March 2019, who underwent PGT-A. Patients were divided into two groups: <3000 IU and >3000 IU, Was evaluating age, dose, mean of days of stimulation, number of biopsied embryos and average number of embryos biopsied in each group. Data were analyzed using the Chi-square, Fisher and Mann Whitney tests. Results: The dose of gonadotrophin (2114.5±537.3UI and 3511.9±319.4UI) (p=0.0001), the days of stimulation (10.1±1.7 and 12.8±2.1) (p=0.001), the number of biopsied embryos (531 x 86), (p=0.05) and the mean number of euploid embryos (1.2±1.3 and 0.5±0.6) (p=0.001) show a significant difference between the groups. However, no difference was observed when we analyzed the number of euploid embryos (p=0.18) and age of the patients (37.4±3.9) (p<0.05). Conclusions: Based on the results obtained, we can conclude that the dose has no relation to the result of embryonic ploidy, however our work shows that patients receiving >3000 IU of gonadotropin is 2.3 times more likely to have no euploid embryo.
P-46. In vitro fertilization with
P-53. Influence of BMI and age
